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ABSTRACT
Sclerosing mesenteritis (SM) is a rare disease with non-specific clinical manifestations and should be 
supported by radiological examination and confirmed by histopathological evaluation. Its relationship with 
cancer especially caecal adenocarcinoma is still unclear. This case report describes a young man who was 
diagnosed as having SM and poorly-differentiated caecal adenocarcinoma.
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ABSTRAK
Sclerosing mesenteritis (SM) merupakan penyakit langka dengan manifestasi klinis tidak spesifik. Diagnosis 
SM didukung dengan pemeriksaan radiologi dan ditegakkan dengan evaluasi histopatologi. Hubungannya 
dengan kanker terutama adenokarsinoma sekum masih belum jelas. Laporan kasus ini memaparkan lelaki muda 
dengan diagnosis SM dan adenokarsinoma sekum berdiferensiasi buruk.
Kata kunci: sclerosing mesenteritis, adenokarsinoma sekum
INTRODUCTION
Sclerosing mesenteritis is an uncommon 
inflammatory disease of the intestinal mesenteric 
fat tissue.1-4 The etiology remains unknown and 
hypothesized to be associated with previous abdominal 
surgery, abdominal trauma, autoimmune disease, drugs, 
cancer, ischemia, and infection.5-7 The prevalence is 
0.16-7.8%. Sclerosing mesenteritis is also reported in 
0.6% of over than 7,000 patients undergoing abdominal 
computed tomography (CT) scan for other indications.8
Clinical manifestations of sclerosing mesenteritis 
(SM) are not specific, varying from asymptomatic to 
Volume 18, Number 2, August 2017 123
Diagnostic Findings of Sclerosing Mesenteritis and the Disease Correlations with Caecal Adenocarcinoma
abdominal pain, bloating, nausea, vomiting, weight 
loss, constipation, diarrhea, and fever.9,10 Diagnosis 
is not always conclusive on clinical findings and 
radiological examinations only. Definitive diagnosis 
is confirmed by histopathological evaluation.11 
In approximately 69% of patients with SM, there 
are some concurrent malignancies such as lymphoma, 
urogenital cancer, and gastrointestinal cancer.12 In case 
series by Vlachos, et al12, 2 of 5 patients had colon 
malignancies (caecal and sigmoid colon cancer). 
Contrary to those reports, other literatures describe 
that the prevalence of cancer in SM patients is not 
different with the general population. The hypothesis 
that supports SM as a paraneoplastic syndrome is still 
controversial.7 
This is a case of a male patient with the diagnosis of 
SM and poorly-differentiated caecal adenocarcinoma. 
The importance of SM diagnostic findings and 
relationship of SM with caecal adenocarcinoma will be 
highlighted. As far as we know, it is the first reported 
case in Indonesia.
CASE ILLUSTRATION
A 45-year-old male was referred to our hospital 
with a chief complaint of continuous vomiting since 
11 days before admission. He had been complaining of 
nausea, vomiting, early satiety, and vague abdominal 
discomfort for the last six months. He was given 
antacids and ranitidine with no improvement. Four 
months ago he underwent an abdominal CT scan, and 
the result showed intestinal and peritoneal TB. He 
refused colonoscopy at the time. Laparoscopic biopsy 
result was suggestive of peritoneal TB. He was given 
anti-TB drugs started four months before admission. 
He consumed anti-TB drugs for only two months 
without any improvements.
Since two months before admission, he had been 
vomiting more frequently. He also had non-bloody 
diarrhea alternating with constipation. He had 
had progressive symptoms and signs of intestinal 
obstruction and underwent laparotomy at another 
hospital. After one month of hospitalization, he was 
discharged. Eleven days before admission, he was 
rehospitalized due to worsening continuous vomiting 
and obstipation. He had involuntary weight loss as 
much as 30 kg within the last four months. 
Physical examination upon admission showed 
that he was fully alert with a body mass index of 
14.7 kg/m2. Nasogastric tube (NGT) was inserted, 
producing greenish-colored fluid followed by coffee-
ground appearance fluid. Abdominal examination 
revealed doughnut-like consistency, dull to percussion, 
decreased abdominal skin turgor and decreased bowel 
sounds. Other physical examinations were within 
normal limits. 
Laboratory examination upon admission 
showed leucocytosis, and decreased albumin levels. 
Carcinoembryonic antigen (CEA) was 10.55 ng/mL 
(normal value 0-4.6 ng/mL). Previous abdominal 
CT scan performed in another hospital showed 
fluid collection surrounding the liver, spleen, 
bilateral paracolic, intestinal, pelvic cavity, with 
mild enhancement in peripheral area. It also showed 
adhesion and inflammation of the small bowel 
beginning from duodenojejunal junction until distal 
ileum, transverse colon, and rectosigmoid colon, 
causing luminal narrowing and dilatation of duodenum 
and gaster. Previous abdominal paracentesis showed 
inconclusive results.
Patient was admitted to our hospital and underwent 
several examinations. Anterograde double balloon 
enteroscopy (DBE) revealed erosive gastropathy with 
gastric mucosal edema and multiple adhesions at the 
jejunum. Nasojejunal feeding tube (NJFT) and NGT 
were inserted for nutritional access and decompression, 
respectively. His repeated abdominal CT scan on the 
sixth day of current hospitalization showed ascites, 
thickening of bowel wall and peritoneum without any 
signs of ileus. 
Figure 1. Coronal contrast-enhanced abdominal CT scan from 
current hospitalization showing thickening of bowel wall, 
ascites, and thickening of peritoneum
The initial results of omentum biopsy from 
another hospital showed non-specific granulomatous 
inflammation without any signs of malignancy. 
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However the specimen was reevaluated in our hospital 
and showed SM with no signs of malignancy.
DISCUSSION
Clinical manifestations of SM are not specific. 
Based on study by Plasencia et al abdominal discomfort 
was reported in two patients, weight loss in four 
patients, nausea in five patients, vomiting in six 
patients, abdominal pain in five patients. Another study 
by Akram et al showed that 10% were asymptomatic, 
70% had abdominal pain, 26% had bloating, 25% 
had diarrhea, 23% had weight loss, 21% had nausea 
and vomiting, 16% had loss of appetite, 15% had 
constipation, 6% had fever, and 3% had night sweats.5,13 
On physical examination, the study showed normal 
abdominal examination in 51% patients, abdominal 
tenderness in 24% patients, abdominal mass in 15% 
patients, and chylous ascites in 14% patients.13 
This patient had nausea, vomiting, early satiety, 
and vague abdominal discomfort. Later on, he also 
complained of diarrhea, constipation, weight loss, 
and signs of abdominal tenderness and intestinal 
obstruction. He had no fever and night sweats. 
Generally, the clinical findings of this patient were in 
concordance with those described in the studies. 
The CT scan findings of SM showed increased 
mesenterium attenuation to a solid soft tissue mass. 
Preservation of fat around the mesenteric vessels which 
is recognized as “fat ring sign” and also calcification 
may be discovered. Significant mesenteric vessels 
involvement could disturb the bowel blood vessel flow 
and cause bowel wall thickening due to ischemia and 
ascites.14
The patient’s abdominal CT scan showed no fat ring 
sign nor calcification. However, there were thickening 
of the small bowel wall and peritoneum. Ascites was 
also identified. Some of the patient’s abdominal CT 
scan findings were in concordance with the literatures. 
Definitive diagnosis of SM requires biopsy and 
histopathological evaluation. Sclerosing mesenteritis 
has been described in three phases. The first phase is 
fat necrosis or mesenteric lipodystrophy. It is followed 
by the second phase, mesenteric panniculitis which 
is related to inflammatory process. The third phase is 
retractile mesenteritis which is marked by fibrosis with 
mesenteric retraction and shortening.15
Evaluation of the biopsy specimen from the 
omentum in our hospital revealed fibrotic tissue, 
adipose tissue, inflammatory cells, congestive vessels 
without specific infection or malignancy. It was 
consistent with SM in the third phase. 
After the thorough explanations regarding the 
diagnostic findings in the above paragraphs, another 
issue of SM emerges. As illustrated in the case, our 
Figure 2. A Hematoxyllin-eosin (HE) staining of omentum 
specimen (40x magnifying power) showing adipose tissue, 
fibrotic tissue, inflammatory cells, congestive vessels 
and absence of malignant cells consistent with sclerosing 
mesenteritis
Colonoscopy was also performed to evaluate the 
possibility of cancer. The procedure revealed that the 
entire colon was edematous and hyperemic and the 
hematoxyllin-eosin (HE) staining of the specimen 
taken from caecum showed poorly-differentiated 
caecal adenocarcinoma.
Figure 3. A Hematoxyllin-Eosin (HE) staining of caecum 
specimen (40x magnifying power) showing trabecular 
tumor cells with pleomorphic nuclei, prominent nucleoli, 
eosinophilic cytoplasm consistent with undifferentiated caecal 
adenocarcinoma
He was given partial parenteral nutrition, intravenous 
fluid, liquid diet via NJFT, and methyl prednisolone 
62.5 mg twice daily intravenously, which was tapered 
down to 16 mg daily for three weeks. The response was 
inadequate and it was decided to do a laparotomy. The 
result was frozen abdomen and the surgery was halted. 
Afterwards, he suffered septic shock due to hospital 
acquired pneumonia and passed away. 
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patient suffered from both SM and poorly differentiated 
caecal adenocarcinoma. Question arises whether it was 
a cause-effect relationship or just a coincidence. 
Some studies were designed to answer the question. 
A research conducted by Gogebakan et al.1 showed 
an interesting fact. They studied 56 patients with 
SM and malignancies compared to 150 patients with 
malignancies and no SM (the control group). From those 
subjects, there were 12 (15.6%) colorectal cancer (CRC) 
patients in SM group and 26 (17.1%) CRC patients in 
control group. The analysis showed non-significant 
differences of CRC prevalence between those two 
groups (p = 0.852).1 The limitations of the study were the 
small number of SM and CRC cases and also the reliance 
of the SM diagnosis on radiological examination only 
and not by histopathology as the gold standard. Another 
study by van Putte-Katier et al.6 contradicts the previous 
research. They studied 46 SM patients with cancer 
and 87 malignancies patients without SM (the control 
group). There were 8 (17.4%) CRC patients in SM 
group and 18 (20.7%) CRC patients in control group. 
The prevalence of CRC was significantly lower in SM 
group compared to control group. The limitation of 
their study was the absence of histopathological proof 
of SM.6 Both studies did not specifically describe the 
location of the CRC (whether it is caecal cancer or not). 
As for know, the relationship between SM and caecal 
adenocarcinoma remains unclear. Further studies are 
needed to clarify this issue. 
In conclusion, sclerosing mesenteritis is a rare 
mesenteric inflammatory disorder, which still has 
vague correlations with cancer, particularly caecal 
adenocarcinoma. Clinical findings of SM are not 
specific and the diagnosis should be supported 
by radiological investigation, and confirmed by 
histopathological examination. 
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